“What we found is that the majority of these companies…offered our ‘secret shopper’ testosterone therapy,” says Joshua A. Halpern, MD, MS.
In this video, Joshua A. Halpern, MD, MS, discusses the background and notable findings from the JAMA Internal Medicine study, “Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms,” for which he served as senior author. Halpern is an assistant professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Destigmatizing Urology: Dr. Amarasekera discusses sexual minorities in urology
January 26th 2022“Gay people have had this history of feeling like the health care system and the structures that are supposed to protect them haven't protected them and kept them safe,” says Channa Amarasekera, MD.
2 Clarke Drive
Cranbury, NJ 08512